Novo Nordisk: Tresiba and Ryzodeg approved in the US

NEUTRAL, Fair Value DKK390 (+5%)
News published on September Monday 28, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities